The effectiveness of cognitive schema therapy on the mixed symptoms of anxiety and depression in breast cancer patients

Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:

The aim of this study was to evaluate the effectiveness of cognitive schema therapy on reducing anxiety and depression in women with breast cancer in Tehran. The research method was a quasi-experimental type of pretest-posttest with a control group. Available or selected voluntarily. Then, the experimental and control groups of 30 were randomly assigned. The twelve-session protocol of Yang schema therapy was performed on the experimental group. Both groups completed the Goldberg and Hiller (1979) General Health Questionnaire in the pre-test and post-test. The results of multivariate analysis of variance showed that Schema therapy was significant in reducing anxiety and depression (p <0.001). Based on this, it can be said that cognitive schema therapy can reduce anxiety and depression in women with breast cancer. For future research, this treatment can be considered as an effective factor in improving the condition of breast cancer patients and increasing their mental health.

Language:
Persian
Published:
Rooyesh-e-Ravanshenasi, Volume:10 Issue: 7, 2021
Pages:
87 to 94
magiran.com/p2346457  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!